Clinical Trial Update: Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACS [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on genotyping-guided, individualized treatment using clopidogrel or ticagrelor in acute coronary syndrome across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: CLOPIDOGREL, POOR METABOLISM of (Disorder) | Phase 2, Phase 3 | Status: UNKNOWN